178 related articles for article (PubMed ID: 25728493)
1. Vagaries of the ELISpot assay: specific detection of antigen responsive cells requires purified CD8(+) T cells and MHC class I expressing antigen presenting cell lines.
Fuchs YF; Jainta GW; Kühn D; Wilhelm C; Weigelt M; Karasinsky A; Upadhyaya B; Ziegler AG; Bonifacio E
Clin Immunol; 2015 Apr; 157(2):216-25. PubMed ID: 25728493
[TBL] [Abstract][Full Text] [Related]
2. The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays.
Britten CM; Meyer RG; Kreer T; Drexler I; Wölfel T; Herr W
J Immunol Methods; 2002 Jan; 259(1-2):95-110. PubMed ID: 11730845
[TBL] [Abstract][Full Text] [Related]
3. HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.
Keane NM; Pavlos RK; McKinnon E; Lucas A; Rive C; Blyth CC; Dunn D; Lucas M; Mallal S; Phillips E
AIDS; 2014 Aug; 28(13):1891-901. PubMed ID: 24911354
[TBL] [Abstract][Full Text] [Related]
4. Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes.
Godard B; Gazagne A; Gey A; Baptiste M; Vingert B; Pegaz-Fiornet B; Strompf L; Fridman WH; Glotz D; Tartour E
Hum Immunol; 2004 Nov; 65(11):1307-18. PubMed ID: 15556681
[TBL] [Abstract][Full Text] [Related]
5. Immunology of Diabetes Society T-Cell Workshop: HLA class I tetramer-directed epitope validation initiative T-Cell Workshop Report-HLA Class I Tetramer Validation Initiative.
Mallone R; Scotto M; Janicki CN; James EA; Fitzgerald-Miller L; Wagner R; Gottlieb P; Thorpe J; Jospe N; Durinovic-Bellò I; Boitard C; Lou O; Dayan CM; Wong FS;
Diabetes Metab Res Rev; 2011 Nov; 27(8):720-6. PubMed ID: 22069251
[TBL] [Abstract][Full Text] [Related]
6. ZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.
Énée É; Kratzer R; Arnoux JB; Barilleau E; Hamel Y; Marchi C; Beltrand J; Michaud B; Chatenoud L; Robert JJ; van Endert P
Diabetes; 2012 Jul; 61(7):1779-84. PubMed ID: 22586580
[TBL] [Abstract][Full Text] [Related]
7. The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients.
Shang XY; Chen HS; Zhang HG; Pang XW; Qiao H; Peng JR; Qin LL; Fei R; Mei MH; Leng XS; Gnjatic S; Ritter G; Simpson AJ; Old LJ; Chen WF
Clin Cancer Res; 2004 Oct; 10(20):6946-55. PubMed ID: 15501973
[TBL] [Abstract][Full Text] [Related]
8. Adenoviral transgene ubiquitination enhances mouse immunization and class I presentation by human dendritic cells.
Rouard H; Klonjkowski B; Marquet J; Lahet C; Mercier S; Andrieu M; Maison P; Molinier-Frenkel V; Eloit M; Farcet JP; Langlade-Demoyen P; Delfau-Larue MH
Hum Gene Ther; 2003 Sep; 14(14):1319-32. PubMed ID: 14503967
[TBL] [Abstract][Full Text] [Related]
9. HLA class I epitope discovery in type 1 diabetes.
van Endert P; Hassainya Y; Lindo V; Bach JM; Blancou P; Lemonnier F; Mallone R
Ann N Y Acad Sci; 2006 Oct; 1079():190-7. PubMed ID: 17130554
[TBL] [Abstract][Full Text] [Related]
10. A sensitive ELISPOT assay for detection of CD8+ T lymphocytes specific for HLA class I-binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
Scheibenbogen C; Lee KH; Mayer S; Stevanovic S; Moebius U; Herr W; Rammensee HG; Keilholz U
Clin Cancer Res; 1997 Feb; 3(2):221-6. PubMed ID: 9815676
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
[TBL] [Abstract][Full Text] [Related]
12. Insect cells as HLA-restricted antigen-presenting cells for the IFN-gamma elispot assay.
Janetzki S; Song P; Gupta V; Lewis JJ; Houghton AN
J Immunol Methods; 2000 Feb; 234(1-2):1-12. PubMed ID: 10669764
[TBL] [Abstract][Full Text] [Related]
13. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
14. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes.
Sarikonda G; Pettus J; Phatak S; Sachithanantham S; Miller JF; Wesley JD; Cadag E; Chae J; Ganesan L; Mallios R; Edelman S; Peters B; von Herrath M
J Autoimmun; 2014 May; 50():77-82. PubMed ID: 24387802
[TBL] [Abstract][Full Text] [Related]
15. Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients.
Xu Y; Theobald V; Sung C; DePalma K; Atwater L; Seiger K; Perricone MA; Richards SM
J Transl Med; 2008 Oct; 6():61. PubMed ID: 18945350
[TBL] [Abstract][Full Text] [Related]
16. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
[TBL] [Abstract][Full Text] [Related]
17. Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.
Coppieters KT; Amirian N; von Herrath MG
Clin Exp Immunol; 2011 Aug; 165(2):155-62. PubMed ID: 21605113
[TBL] [Abstract][Full Text] [Related]
18. The use of clonal mRNA as an antigenic format for the detection of antigen-specific T lymphocytes in IFN-gamma ELISPOT assays.
Britten CM; Meyer RG; Frankenberg N; Huber C; Wölfel T
J Immunol Methods; 2004 Apr; 287(1-2):125-36. PubMed ID: 15099761
[TBL] [Abstract][Full Text] [Related]
19. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
[TBL] [Abstract][Full Text] [Related]
20. Equivalent specificity of peripheral blood and islet-infiltrating CD8+ T lymphocytes in spontaneously diabetic HLA-A2 transgenic NOD mice.
Enée E; Martinuzzi E; Blancou P; Bach JM; Mallone R; van Endert P
J Immunol; 2008 Apr; 180(8):5430-8. PubMed ID: 18390725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
